Articles

HairClone Interview With Paul Kemp: Part 2

January 25, 2019 /

Please enjoy the second part of our interview series with Paul Kemp PhD, CEO of HairClone. FT: Can you give us a step-by-step of how a therapy like HairClone’s goes from the R&D phase into the clinical setting? PK: If you consider it at its very simplest there are 4 players involved in any treatment. The…

Read More

RiverTown Therapeutics Melanocyte Research

January 22, 2019 /

RiverTown Therapeutics has engaged in an academic research collaboration to validate an effect of RT1640 that has already been observed in humans – gray hair reversal. A collaboration has begun between RiverTown Therapeutics and The University of Alabama at Birmingham with well-known hair pigment researcher Dr. Melissa Harris. You may remember Dr. Melissa Harris as…

Read More

Official Trinov Product Review Page

January 9, 2019 /

Updated It’s been over a month since the long anticipated Trinov product was released in Italy. Across the internet you can find people sharing stories of their Trinov orders arriving. Now that the product is widely available and several readers of Follicle Thought have shared that they are now using the product, it’s time to…

Read More

HairClone Interview With Paul Kemp: Part 1

December 24, 2018 /

Happy Holidays to all of the readers of Follicle Thought. I’m pleased to be bringing you all an exclusive interview with the UK-based startup HairClone, I hope you enjoy it with your celebrations this year. As many of you know, HairClone has recently launched a crowdfunding campaign in order to advance its R&D and setup…

Read More

HairCell Launches Clinical Trial

December 12, 2018 /

A clinical trial has begun for HairCell, a startup in the Leonhardt Ventures portfolio which seeks to rejuvenate hair using bioelectric stimulation and biologics. Leonhardt Ventures is a regenerative medtech company which is developing around 30 startup companies for various types of organ regeneration and recovery. The core technology of all of these companies is…

Read More

Cosmetics Business Hair Industry Report

December 5, 2018 /

In November, the UK based magazine “Cosmetic Business” released a Trend Report on the latest happenings in the hair growth industry. The November Trend Report features commentary from several hair transplant surgeons and also from yours truly, FollicleThought.com. On The Horizon Within the article, hair transplant surgeon Dr. Robert Jones endorses HairClone on being at…

Read More

Trinov Launch Press Release + New Photos

November 29, 2018 /

Fidia Pharma held a press conference on November 29, 2018 announcing the arrival of Trinov hair growth lotion at pharmacies in Italy. The press release was shared in the news section of Fidia’s website, only in the Italian version of the website. Upon first glance this was good news to read, however when I clicked on…

Read More

HairClone Launches Crowdfunding Campaign

November 9, 2018 /

(Update: Minimum investment in HairClone is now £100) HairClone, a UK based company working on cellular hair restoration therapies, has announced the launch of its public crowdfunding campaign today. Please enjoy the introductory HairClone crowdfunding video below. To launch the campaign HairClone has teamed up with Capital Cell, a European based equity crowdfunding company which specializes…

Read More

Medipost: NGF-574H Hair Growth Product Presentation

November 7, 2018 /

Today, I will be sharing some expanded information I have received about the exciting new hair growth cosmetic “NGF-574H” from Medipost of South Korea.  Earlier this year in May, I initially covered Medipost’s development of NGF-574H. The product itself is a stem cell-derived serum which has been tailored to be effective at preventing hair loss…

Read More

Samumed Phase 3 Trial Is Underway

November 5, 2018 /

Updated 2/28/20 Samumed SM04554 Phase 3 Trial Is Now Fully Enrolled  In a company newsletter published on February 28, 2020, Samumed announced that their phase 3 trial of SM04454 in AGA has finally reached its quota of trial participants. That quota was a whopping 625 male subjects between the ages of 18 – 45 years…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.